Olink Holding是一家蛋白质组学平台,该平台提供用于生物医学研究的蛋白质组分析产品,主要用来多重蛋白质生物标志物免疫测定。Thermo Fisher Scientific(赛默飞)即将完成对知名非质谱蛋白组学龙头瑞典Olink Holding AB(Olink)的收购,将斥资31亿美元。
64折起 赛默飞生命科学学堂 系统全面的金牌课程 助力中国生命科学科研研发 开始学习 赛家课堂 一键下单,无需促销码 认准官网飞享价,享超值折扣,尽享便捷 立即搜索订购 无需促销码 来掌上赛默飞,享秒杀,赢好礼 易查找、易购买、易联系,活动多多,好礼多多 ...
Our company is uniquely positioned to bring this technology to customers enabling them to meaningfully accelerate discovery and scientific breakthroughs. We look forward to welcoming Olink’s colleagues to Thermo Fisher.” Jon Heimer, CEO of Olink said...
Olink Holding是一家蛋白质组学平台,该平台提供用于生物医学研究的蛋白质组分析产品,主要用来多重蛋白质生物标志物免疫测定。Thermo Fisher Scientific(赛默飞)即将完成对知名非质谱蛋白组学龙头瑞典Olink Holding AB(Olink)的收购,将斥资31亿美元。(IT桔子)
Set up Olink in your lab Proximity Extension Assay A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis. Application Application Disease areas Population-scale proteogenomics Biomarker discovery to clinical utility ...
To learn more about the Olink Platform, please visitwww.thermofisher.com/olink AboutThermo Fisher Scientific Thermo Fisher Scientific Inc.(NYSE: TMO) is the world leader in serving science, with annual revenue over$40 billion. Our Mission is to enable our customers to make the world healthier,...
Thermo Fisher’s Sales Missed Forecasts. Its Stock Is Down on Different Bad News. Oct. 17, 2023 9:02 a.m. ET Thermo Fisher to Buy Sweden’s Olink for a 74% Premium in $3.1 Billion Deal Sept. 1, 2023 12:19 p.m. ET Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Appr...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Highlights Fourth quarter revenue was $10
Thermo Fisher Scientific即将完成对Olink收购 Olink Holding是一家蛋白质组学平台,该平台提供用于生物医学研究的蛋白质组分析产品,主要用来多重蛋白质生物标志物免疫测定。Thermo Fisher Scientific(赛默飞)即将完成对知名非质谱蛋白组学龙头瑞典Olink Holding AB(Olink)的收购,将斥资31亿美元。
the Thermo Scientific iCAP MX Series ICP-MS and new additions to the Gibco CTS Detachable Dynabeads platform. Additionally, in 2024, Thermo Fisher completed the acquisition of Olink, a leading provider of advanced solutions for proteomics research. All these developments translated into meaningful comme...